BRAF is the most commonly altered molecular driver in pediatric low-grade gliomas [20], with BRAF V600E mutations being more frequent in pleomorphic xanthoastrocytoma (PXA) and ganglioglioma (GG) [20,21]. This evidence concerns the gene BRAF and ganglioglioma.